Socorro, NM, United States of America

Igov V Magedov

This inventor holds 1 USPTO granted patent. Top assignee: New Mexico Technical Research Foundation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Igov V Magedov. Retrieved from https://idiyas.com/inventor/igov-v-magedov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Igov V Magedov: Innovator in Pharmaceutical Compounds

Introduction

Igov V Magedov is a notable inventor based in Socorro, New Mexico. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical disorders. His work focuses on innovative solutions that enhance treatment efficacy.

Latest Patents

Igov V Magedov holds a patent for "Pyrano [3,2-C] pyridones and related heterocyclic compounds as pharmaceutical agents for treating disorders responsive to apoptosis, antiproliferation or vascular disruption, and the use thereof." This patent includes a pharmaceutical composition comprising a pharmaceutically acceptable excipient or carrier and a compound Formula I, or a pharmaceutically acceptable salt or prodrug thereof. He has 1 patent to his name.

Career Highlights

Magedov is associated with the New Mexico Technical Research Foundation, where he applies his expertise in pharmaceutical research. His work has been instrumental in advancing the understanding of compounds that can effectively treat various health conditions.

Collaborations

Throughout his career, Igov has collaborated with notable colleagues, including Alexander Kornienko and Snezna Rogelj. These partnerships have contributed to the development of innovative pharmaceutical solutions.

Conclusion

Igov V Magedov's contributions to the field of pharmaceuticals highlight his dedication to innovation and research. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…